[Active site of soluble 17-beta-hydroxysteroid: NAD (P) oxidoreductase from the human placenta].
D000731:Androstanes; D001565:Benzoates; D001665:Binding Sites; D002210:Caprylates; D055598:Chemical Phenomena; D002621:Chemistry; D003080:Cold Temperature; D004583:Electrons; D004958:Estradiol; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors; D007700:Kinetics; D010795:Phthalic Acids; D010920:Placenta / Q000201:enzymology*; D011549:Pseudomonas / Q000201:enzymology; D011725:Pyridines; D013237:Stereoisomerism
D000731:Androstanes; D001565:Benzoates; D002210:Caprylates; D010795:Phthalic Acids; D011725:Pyridines; D004958:Estradiol; D006913:Hydroxysteroid Dehydrogenases
Etude du site actif de al 17-beta-hydroxystéroïde: NAD (P) oxydoréductase soluble du placenta humain.